This inventor holds 3 USPTO granted patents. Top assignee: University of Massachusetts. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovations and Contributions of Inventor Xiaofei E
Introduction
Xiaofei E is a notable inventor based in Westborough, MA (US). He has made significant contributions to the field of medical research, particularly in the area of viral infections and tissue preservation. With a total of 3 patents, his work has the potential to impact patient care and treatment outcomes.
Latest Patents
Xiaofei E's latest patents include innovative methods for addressing critical health issues. One of his patents focuses on "Targeting cell tropism receptors to inhibit cytomegalovirus infection." This invention outlines methods for treating or reducing the risk of cytomegalovirus infection by administering inhibitors of specific receptors. Another significant patent is titled "Methods for preventing graft ischemia reperfusion injury during ex vivo machine perfusion preservation." This invention provides methods for treating ischemia in transplant donor tissue, utilizing RNA interference to mitigate ischemic injury and enhance tissue acceptance.
Career Highlights
Xiaofei E is affiliated with the University of Massachusetts, where he continues to advance his research and innovations. His work is characterized by a commitment to improving medical treatments and enhancing the efficacy of transplant procedures.
Collaborations
Throughout his career, Xiaofei E has collaborated with esteemed colleagues, including Timothy F Kowalik and Abraham L Brass. These partnerships have fostered a collaborative environment that promotes innovative research and development.
Conclusion
Xiaofei E's contributions to medical research through his patents demonstrate his dedication to addressing significant health challenges. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
